Drug profile · INN
methylthioninium chloride
METHYLTHIONINIUM CHLORIDE PROVEBLUE
methylthioninium chloride (METHYLTHIONINIUM CHLORIDE PROVEBLUE) is a soluble guanylate cyclase inhibitor.
EMA: approved Various (V03) V03AB17
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — methylthioninium chloride
- Class
- Various (V03)
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.83
Quick answer
methylthioninium chloride (METHYLTHIONINIUM CHLORIDE PROVEBLUE) is a soluble guanylate cyclase inhibitor.
Key facts
INN methylthioninium chloride
Brand METHYLTHIONINIUM CHLORIDE PROVEBLUE
Mechanism Soluble guanylate cyclase inhibitor
Target Soluble guanylate cyclase
Therapeutic class Various (V03)
ATC code V03AB17
Mechanism of action
Soluble guanylate cyclase inhibitor
Primary target: Soluble guanylate cyclase
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
Related & competitor drugs
Frequently asked questions
What is methylthioninium chloride?
methylthioninium chloride (METHYLTHIONINIUM CHLORIDE PROVEBLUE) is a soluble guanylate cyclase inhibitor.
What is the brand name for methylthioninium chloride?
METHYLTHIONINIUM CHLORIDE PROVEBLUE is a marketed brand name for methylthioninium chloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.